Tick-Borne lymphadenopathy: A new infectious disease in children

Pediatric Infectious Disease Journal

Volumn 27, Issue 7, 2008, Pages 618-622

  Porta, Ferran Segura ^a,b,c   Nieto, Esperanza Antón ^a,b   Creus, Bernat Font ^a   Espín, Tomás Muñoz ^c   Casanova, Francisco Javier Travería ^c   Sala, Isabel Sanfeliu ^a,d   García, Sergio Lario ^a   Aguilar, Jesus Luelmo ^a   Vilaseca, Mariela Quesada ^a,b  

^a Hospital Universitari Parc Taulí   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Department of Paediatrics ^*  (Spain)

^d UDIAT   (Spain)

Author keywords

Dermacentor marginatus; Rickettsia slovaca; TIBOLA; Tick borne lymphadenopathy

Indexed keywords

CLARITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; JOSAMYCIN; ANTIINFECTIVE AGENT; BACTERIAL DNA;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BORRELIA BURGDORFERI; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMACENTOR PARUMAPERTUS; DNA SEQUENCE; EPIDEMIC; ERYTHEMA; HUMAN; INOCULATION; LYMPHADENOPATHY; NECROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RICKETTSIA CONORII; RICKETTSIA SLOVACA; SCALP; SEASONAL VARIATION; SEROLOGY; SKIN BIOPSY; SPAIN; SYMPTOMATOLOGY; TICK BITE; TICK BORNE DISEASE; TICK BORNE LYMPHADENOPATHY; ADOLESCENT; ANIMAL; DERMACENTOR; DNA FINGERPRINTING; FEMALE; GENETICS; INSECT BITE; ISOLATION AND PURIFICATION; LYME DISEASE; LYMPHATIC SYSTEM DISEASE; MALE; METHODOLOGY; MICROBIOLOGY; PATHOLOGY; RICKETTSIA; RICKETTSIOSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANIMALS; ANTI-BACTERIAL AGENTS; BORRELIA BURGDORFERI; CHILD; DERMACENTOR; DNA FINGERPRINTING; DNA, BACTERIAL; FEMALE; HUMANS; INSECT BITES AND STINGS; LYME DISEASE; LYMPHATIC DISEASES; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RICKETTSIA; RICKETTSIA INFECTIONS; SEQUENCE ANALYSIS, DNA; SPAIN; TICK-BORNE DISEASES; TREATMENT OUTCOME;

EID: 50949085718     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31816b1947     Document Type: Article

References (36)

1. Parola P, Paddock CD, Raoult D. Tick-borne rickettsioses around the world: emerging diseases challenging old concepts. Clin Microbiol Rev. 2005;18:719-756.
2. Bernabeu-Wittel M, Segura-Porta F. Enfermedades producidas por Rickettsia. Enferm Infecc Microbiol Clin. 2005;23:163-172.
3. Raoult D, Lakos A, Fenollar F, Beytout J, Brouqui P, Fournier PE. Spottless Rickettsiosis caused by Rickettsia slovaca and associated with Dermacentor ticks. Clin Infect Dis. 2002;34:1331-1336.
4. Raoult D, Roux V. Rickettsiosis as paradigms of new or emerging infectious diseases. Clin Microbiol Rev. 1997;10:694-719.
5. Antónt B, Mun ∼ Sanfeliu I, Segura F. Clinical and laboratory characteristics of 144 patients with Mediterranean spotted fever. Eur J Clin Microbiol Infect Dis. 2003;22:126-128.
6. Segura F, Font B. Resurgence of Mediterranean spotted fever in Spain. Lancet. 1982;2:280.
7. Font B, Bella F, Espejo E, et al. Mediterranean spotted fever: a cooperative study of 227 cases. Rev Infect Dis. 1985;7:635-642.
8. Font B, Espejo E, Mun ∼ Uriz S, Bella F, Segura F. Fiebre botonosa mediterra ́tudio de 246 casos. Med Clin (Barc). 1991;96:121-125.
9. Lakos A. Tick-borne lymphadenopathy-a new rickettsial disease? Lancet. 1997;350:1006.
10. Lakos A. TIBOLA-a new tick-borne infection. Orv Hetil. 1997;138: 3229-3232.
11. Lakos A. Tick-borne lymphadenopathy (TIBOLA). Wien Klin Wochenschr. 2002;114:648-654.
12. Lakos A. Tick-borne lymphadenopathy (TIBOLA)-a new, probably rickettsial infection. Infect Dis Rev. 1999;1:114-116.
13. Regnery RL, Spruill CL, Plikaytis BD. Genotypic identification of rickettsiae and estimation of intraspecies sequence divergence for portions of two rickettsial genes. J Bacteriol. 1991;173:1576-1589.
14. Eremeeva M, Yu XJ, Raoult D. Differentiation among spotted fever group rickettsia species by analysis of restriction fragment length polymorphism of PCR-amplified DNA. J Clin Microbiol. 1994;32:803-810.
15. Pierce KE, Sanchez JA, Rice JE, Wangh LJ. Linear-After-The-Exponential (LATE)-PCR: primer design criteria for high yields of specific single-stranded DNA and improved real-time detection. Proc Natl Acad Sci. 2005;102:8609-8614.
16. Ngwamidiba M, Blanc G, Raoult D, Fournier PE. Sca1, a previously undescribed paralog from autotransporter protein-encoding genes in Rickettsia species. BMC Microbiol. 2006;6:12.
17. Oteo JA, Ibarra V, Blanco JR, et al. Dermacentor-borne necrosis erythema and lymphadenopathy: clinical and epidemiologic features of a new tick-borne disease. Clin Microbiol Infect. 2004;10:327-331.
18. Lakos A, Raoult D. Tick-borne lymphadenopathy (TIBOLA) a Rickettsia slovaca infection? In: Rickettsiae and Rickettial Diseases at the Turn of the Third Millennium. Paris: Elsevier; 1999:258:-261.
19. Gouriet F, Rolain JM, Raoult D. Rickettsia slovaca infection, France. Emerg Infect Dis. 2006;12:521-523.
20. Mittermayer T, Brezina R, Úyi J. First report of an infection with Rickettsia slovaca. Folia Parasitol (Praha). 1980;27:373-376.
21. Rehacek J, Nosek J, Urvolgyi J, Sztankay M. Rickettsiae of the spotted fever group in Hungary. Folia Parasitol (Praha). 1979;26:367-371.
22. Bacellar F, Nu ́, Alves MJ, Filipe AR. Rickettsia slovaca: un agente del grupo de las fiebres exantema ́en Portugal. Enferm Infecc Microbiol Clin. 1995;13:218-223.
23. Punda V, Petrovec M, Trilar T, et al. Detection and identification of spotted fever group rickettsiae in ticks collected in southern Croatia. Exp Appl Acarol. 2002;28:169-176.
24. Sanogo YO, Davoust B, Parola P, Camicas JL, Brouqui P, Raoult D. Prevalence of Rickettsia spp. In Dermacentor marginatus Ticks Removed from Game Pigs (Sus scrofa) in Southern France. Ann N Y Acad Sci. 2003;990:191-195.
25. Ortun ∼Quesada M, Lo ́et al. Prevalence of Rickettsia slovaca in Dermacentor marginatus ticks removed from wild boar (Sus scrofa) in northeastern Spain. Ann N Y Acad Sci. 2006;1078:324-327.
26. Oteo JA, Portillo A, Santiba ́n ∼ez S, et al. Prevalence of SFG rickettsia species detected in ticks in La Rioja, Spain. Ann N Y Acad Sci. 2006;1078:320-323.
27. Márquez FJ, Hidalgo A, Contreras F, Rodríguez J, Muniain MA. Las garrapatas como transmisores y reservorios de microorganismos pato ́g-enos en Espan ∼a. Enferm Inf Microbiol Clin. 2005;23:94-102.
28. Raoult D, Berbis P, Roux V, Xu W, Maurin M. A new tick-transmitted disease due to Rickettsia slovaca. Lancet. 1997;350:112-113.
29. Cazorla C, Enea M, Lucht F, Raoult D. First isolation of Rickettsia slovaca from a patient, France. Emerg Infect Dis. 2003;9:135.
30. Marquez FJ, Ibarra V, Oteo JA, Muniain MA. Which spotted fever group Rickettsia are present in Dermecentor marginatus ticks in Spain? Ann N Y Acad Sci. 2003;990:141-142.
31. Ibarra V, Blanco JR, Portillo A, Santiba ́n ∼ez S, Metola L, Oteo JA. Effect of Antibiotic Treatment in Patients with DEBONEL/TIBOLA. AnnNY Acad Sci. 2005;1063:257-258.
32. Bella F, Font B, Segura F, Espejo E, Lo ́pez P, Mun ∼oz T. Comparative randomized trial of one-day doxycycline versus 10-day tetracycline therapy for Mediterranean spotted fever. J Infect Dis. 1987;155:1025-1058.
33. Mun ∼ozT,Lo ́pez P, Espejo E, et al. Erythromycin versus tetracycline for treatment of Mediterranean spotted fever. Arch Dis Child. 1986;61: 1027-1029.
34. Bella F, Font B, Uritz S, et al. Randomized trial of doxycycline versus josamycin for Mediterranean spotted fever. Antimicrob Agents Chemother. 1990;34:937-938.
35. Cascio A, Colomba C, Antinori S, Paterson DL, Titone L. Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: a randomized controlled trial. Clin Infect Dis. 2002;34:154-158.
36. Segura F, Anto ́n E. Clarithromycin in the treatment of Mediterranean spotted fever. Clin Infect Dis. 2002;34:560.